Usfda Post Approval Changes
Akeem Rippin
—
ter innovation while ensuring product quality and patient safety are not compromised. Furthermore, the FDA’s recent guidance on the Chemistry, Manufacturing, and Controls (CMC) post approval change management protocols (PACMP) reflects a move toward more flexible change
